Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)

OBJECTIVE: To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns <28 weeks. METHODS: We performed a secondary analysis of the multi-center PDA-TOLERATE trial (NCT01958320). Infants with moderate-to-large PDAs were randomized 1:1 at 8.1±2.1 days to eit...

Full description

Bibliographic Details
Main Authors: Liebowitz, Melissa, Kaempf, Joseph, Erdeve, Omer, Bulbul, Ali, Håkansson, Stellan, Lindqvist, Johanna, Farooqi, Aijaz, Katheria, Anup, Sauberan, Jason, Singh, Jaideep, Nelson, Kelly, Wickremasinghe, Andrea, Dong, Lawrence, Hassinger, Denise C., Aucott, Susan W., Hayashi, Madoka, Heuchan, Anne Marie, Carey, William A., Derrick, Matthew, Wolf, Ilene Sue, Kimball, Amy, Sankar, Meera, Leone, Tina, Perez, Jorge, Serize, Arturo, Clyman, Ronald I.
Format: Online Article Text
Language:English
Published: 2019
Subjects:
Article
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Similar Items